BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37650885)

  • 1. Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study.
    Infante J; Esteves G; Raposo J; de Lacerda JF
    Ann Hematol; 2023 Nov; 102(11):3031-3037. PubMed ID: 37650885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.
    Infante JB; Esteves GV; Raposo J; de Lacerda JF
    Eur J Haematol; 2024 May; 112(5):840-844. PubMed ID: 38305491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S; Ge Y; Li Z; Yang T
    Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
    Baysal M; Gürsoy V; Hunutlu FC; Erkan B; Demirci U; Bas V; Gulsaran SK; Pinar IE; Ersal T; Kirkizlar TA; Atli EI; Kirkizlar HO; Ümit EG; Gürkan H; Ozkocaman V; Ozkalemkas F; Demir AM; Ali R
    Ann Hematol; 2022 May; 101(5):1049-1057. PubMed ID: 35190843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
    Xiao M; Zhou P; Liu Y; Wei S; Li D; Li W; Niu X; Niu J; Zhang Y; Cao W; Liu B; Wang X; Bai Y; Sun K
    Thromb Res; 2022 Feb; 210():33-41. PubMed ID: 34998209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Abla O; Ribeiro RC; Testi AM; Montesinos P; Creutzig U; Sung L; Di Giuseppe G; Stephens D; Feusner JH; Powell BL; Hasle H; Kaspers GJL; Dalla-Pozza L; Lassaletta A; Tallman MS; Locatelli F; Reinhardt D; Lo-Coco F; Hitzler J; Sanz MA
    Ann Hematol; 2017 Sep; 96(9):1449-1456. PubMed ID: 28597167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation.
    Lee HJ; Park HJ; Kim HW; Park SG
    Blood Res; 2013 Dec; 48(4):250-3. PubMed ID: 24466548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
    Huang YT; Liu XF; Fu RF; Chen YF; Liu W; Xue F; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):480-484. PubMed ID: 30032565
    [No Abstract]   [Full Text] [Related]  

  • 11. Early Mortality in Children and Adolescents with Acute Promyelocytic Leukemia: Experience of the Boldrini Children's Center.
    de Azevedo AC; Matsuda E; Cervellini JY; Prandi LR; Omae C; Jotta PY; Pereira RM; Brandalise SR
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e641-e646. PubMed ID: 31613846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia.
    Mitrovic M; Suvajdzic N; Bogdanovic A; Kurtovic NK; Sretenovic A; Elezovic I; Tomin D
    Med Oncol; 2013 Mar; 30(1):478. PubMed ID: 23371042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience.
    Akcay OF; Yeter HH; Buyukasik Y
    Rom J Intern Med; 2020 Sep; 58(3):138-145. PubMed ID: 32452194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study.
    Guo Z; Chen X; Tan Y; Xu Z; Xu L
    Blood Cells Mol Dis; 2020 Mar; 81():102393. PubMed ID: 31918382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
    Li S; Gao Y; Li F; Zheng Y; Su Y
    Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
    Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients: A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals.
    Patel R; Patel D; Patel M; Ohemeng-Dapaah J; Onyechi A; Patel Z; Yang C; Shaikh S
    Turk J Haematol; 2024 Mar; 41(1):1-8. PubMed ID: 38374587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.
    Hou W; Zhang Y; Jin B; Cao W; Lu M; Yan L; Yang H; Tian X; Hou J; Fu J; Zhao H; Li H; Zhou J
    Blood Cells Mol Dis; 2019 Nov; 79():102351. PubMed ID: 31400712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.
    Wen J; Xu F; Zhou Q; Shi L; Liu Y; Yue J; Zhang Y; Liang X
    BMC Cancer; 2023 Jan; 23(1):27. PubMed ID: 36611025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.